Edmond De Rothschild Holding S.A. Baudax Bio, Inc. Transaction History

Edmond De Rothschild Holding S.A.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 09, 2023	SELL	$0.12 - $5.2 $334 - $14,487	-2,786 Reduced 97.51%	71 $0
Q3 2022 Nov 09, 2022	BUY	$0.26 - $0.87 $742 - $2,485	2,857 New	2,857 $1,000

Ticker BXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,003,700
Market Cap $200K
Description
Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with non-NSAID analgesics. Its products under development includes BX1000, an intermediate-acting neuro...

Get notified when there are updates to the investment portfolio of Edmond De Rothschild Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Edmond De Rothschild Holding S.A. with notifications on news.